Celltex News
Houston regenerative medicine leaders host delegation from Mexico
A blue ribbon delegation, composed of representatives from the offices of the Secretary of Health of Mexico, the Commission for the Protection against Sanitary Risk (COFEPRIS) — the equivalent of the U.S. FDA in Mexico — and The National Institute of Public Health Mexico (INSP) — the equivalent of the U.S. NIH in Mexico — recently spent two days in Houston and College Station. The purpose of their trip was to meet with leading researchers and doctors to explore the latest regenerative medicine advancements, specifically those using autologous mesenchymal stem cells. The visit was initiated by David Eller, CEO of Houston-based biotechnology company Celltex Therapeutics Corporation.
“We were honored to host these esteemed experts, who came to Houston to learn about our company,” says Eller. “We are excited about their expressed interest in establishing shared relationships with Celltex and other leaders in their respective fields who are using autologous stem cells to initiate technological breakthroughs in the accelerating field of regenerative medicine.”
PHOTO: The delegation visited Houston-based biotechnology company, Celltex. From left to right: Luis Ortiz Blas (INR); Dr. Ana Luisa Sesman Bernal (COFEPRIS); Julio Sánchez y Tépoz (COFEPRIS); José Clemente Ibarra Ponce de León (INR); Dr. Guillermo M. Ruiz-Palacios (INSP); David Eller (Celltex); Dr. Stan Jones (Celltex); Alejandro Sanders (INR); Erik Eller (Celltex)
The delegation met with Dr. Darwin J. Prockop, Director of the Institute for Regenerative Medicine, Texas A&M College of Medicine – Texas A&M University; Dr. Philip A. Salem, a physician, researcher, educator and international statesman in cancer medicine, and President of Salem Oncology Center in Houston; Dr. Mark Adickes, Chief of the Division of Sports Medicine at Baylor College of Medicine; Dr. Stanley Jones, Celltex Chief Medical Officer and Dr. Jane Young, Celltex Chief Scientific Officer, as well as other researchers from Houston’s regenerative medicine community.
Post Tags: business development
More Recent News
From Totipotent to Unipotent: Understanding Stem Cell Types and Differentiation Potential
Although stem cell therapy’s future applications and potential are still being investigated, stem cells have revolutionized the landscape of medicine, offering a promising therapy option for many conditions and diseases.
However, if you’re interested in receiving stem cell therapy in the future, be aware that not all stem cells are the same. It’s important to understand the differences between various types of stem cells and which ones are utilized in regenerative medicine.
Read MoreWhat Is Stem Cell Banking?
Thanks to advancements in stem cell research, particularly the recognition of the regenerative properties of Mesenchymal Stem Cells (MSCs), Adult Stem Cell Banking has become a versatile and promising avenue for accessing personalized healthcare and future therapeutic interventions.
In this article, we describe the Stem Cell Banking process in detail and explain how it may greatly increase the potential for positive results when therapeutic application is necessary.
Read More